emergence agitation
Conditions
Interventions
experimental roup:Intravenous ibuprofen
control group:placebo
Sponsors
Beijing Children's Hospital, Capital Medical University, National Center for Children's Health
Eligibility
Sex/Gender
All
Age
3 Years to 9 Years
Inclusion criteria
Inclusion criteria: 1. Aged 3-9 years. 2. With an American Society of Anesthesiologists (ASA) risk score of I–II. 3. Receive selective tonsillectomy (with or without adenoidectomy). 4. Before the start of any activities related to the trial, the subjects legal guardian signs an informed consent, has a full understanding of the purpose and significance of the trial, and is willing to abide by the trial protocol.
Exclusion criteria
Exclusion criteria: 1. With allergy to the study drugs. 2. With bleeding tendency. 3. With abnormal electrolyte balance. 4. With neurological, neuromuscular. 5. With renal or hepatic disease. 6. With craniofacial abnormalities. 7. With cardiac or respiratory disease. 8. With hypertension. 9. With Aspirin sensitive asthma. 10. In a coma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| emergence agitation; | — |
Secondary
| Measure | Time frame |
|---|---|
| pain;emergence time;remedy;postoperative nausea and vomiting; | — |
Countries
China
Contacts
Public ContactGao Zhengzheng
Beijing Children's Hospital, Capital Medical University, National Center for Children's Health
Outcome results
None listed